Physician

Michael Don Canty, M.D.

According to 2025 Medicare claims, Michael Canty, M.D. (NPI: 1003912783) practices gastroenterology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Boyd, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1861718199; TIN: 264183569) and primary practice location at 41101-2843.

Canty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 590 traditional Medicare patients, billed 1,125 HCPCS/CPT codes, and received $105,554 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 434 prescription claims across 149 beneficiaries totaling $34,396 in drug costs, led by Sucralfate (Sucralfate). 2017 DME data shows 11 claims. Open Payments data shows 54 records totaling $1,037. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $326,104 to $105,554. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $318,253 to $34,396. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,286	3,468	$326,104
2016	1,199	2,471	$225,209
2017	1,102	3,186	$220,535
2018	1,050	3,253	$225,245
2019	973	2,953	$211,079
2020	692	1,893	$145,819
2021	724	1,475	$153,208
2022	662	1,387	$126,530
2023	626	1,381	$123,572
2024	590	1,125	$105,554

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	578	2,676	$318,253
2016	448	1,518	$150,337
2017	381	1,141	$144,938
2018	372	1,190	$290,296
2019	311	852	$56,556
2020	231	685	$50,362
2021	268	802	$78,261
2022	228	568	$60,023
2023	180	431	$23,796
2024	149	434	$34,396

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$2,233
2016	N/R	68	$2,344
2017	N/R	11	$755
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	159	159	$156
45378	Diagnostic exam of large bowel using a flexible endoscope	83	83	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	142	$82
45380	Biopsy of large bowel using a flexible endoscope	114	114	$80
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	241	249	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucralfate	Sucralfate	31	1,235	$2,003
Dicyclomine Hcl	Dicyclomine Hcl	71	2,476	$1,023
Pantoprazole Sodium	Pantoprazole Sodium	75	3,789	$752
Omeprazole	Omeprazole	91	3,872	$580
Esomeprazole Magnesium	Esomeprazole Magnesium	14	600	$333

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,037	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Don Canty, M.D.?

Tedicare shows public-source Medicare data for Michael Don Canty, M.D. (NPI 1003912783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Don Canty, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Don Canty, M.D.?

Michael Don Canty, M.D. is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1861718199) in the available physician profile data.

Does Michael Don Canty, M.D. have Open Payments data?

Michael Don Canty, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.